Metraipolis › archive › dc_faa71d330cf6
Neutropenia and infectious events during off-label treatment with venetoclax in children with malignant disease: a pharmacovigilance analysis of FDA adverse… — Europe PMC PMID:42026320
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42026320
- DOI
- 10.1007/s00277-[numero omesso]-z
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T10:48:06.070Z
- SHA-256 of the archived text
864abcd9f43d00b436c365453194ad84235709bb48134f0ab5777b3a6b2d366e- Stable URL of this page
https://metraipolis.com/documento/dc_faa71d330cf6
How to cite
Neutropenia and infectious events during off-label treatment with venetoclax in children with malignant disease: a pharmacovigilance analysis of FDA adverse… — Europe PMC PMID:42026320 — Europe PMC (en), https://europepmc.org/article/MED/42026320 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_faa71d330cf6 (Metraipolis archive dc_faa71d330cf6, sha256 864abcd9f43d00b436c365453194ad84235709bb48134f0ab5777b3a6b2d366e)
BibTeX
@misc{dcfaa71d330cf6,
title = {Neutropenia and infectious events during off-label treatment with venetoclax in children with malignant disease: a pharmacovigilance analysis of FDA adverse… — Europe PMC PMID:42026320},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42026320},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_faa71d330cf6; sha256 864abcd9f43d00b436c365453194ad84235709bb48134f0ab5777b3a6b2d366e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42026320. Agents can read the archived copy with the MCP tool read_document.